JP2014529614A - 放射線により誘発されるまたは化学療法により誘発される肺機能不全の治療または予防のための組成物および方法 - Google Patents

放射線により誘発されるまたは化学療法により誘発される肺機能不全の治療または予防のための組成物および方法 Download PDF

Info

Publication number
JP2014529614A
JP2014529614A JP2014527498A JP2014527498A JP2014529614A JP 2014529614 A JP2014529614 A JP 2014529614A JP 2014527498 A JP2014527498 A JP 2014527498A JP 2014527498 A JP2014527498 A JP 2014527498A JP 2014529614 A JP2014529614 A JP 2014529614A
Authority
JP
Japan
Prior art keywords
csf
composition
radiation
use according
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014527498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014529614A5 (enExample
Inventor
ラース・ヘスレト
Original Assignee
トリフォイリウム・エピエス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by トリフォイリウム・エピエス filed Critical トリフォイリウム・エピエス
Publication of JP2014529614A publication Critical patent/JP2014529614A/ja
Publication of JP2014529614A5 publication Critical patent/JP2014529614A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
JP2014527498A 2011-08-29 2012-08-29 放射線により誘発されるまたは化学療法により誘発される肺機能不全の治療または予防のための組成物および方法 Pending JP2014529614A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161528459P 2011-08-29 2011-08-29
US61/528,459 2011-08-29

Publications (2)

Publication Number Publication Date
JP2014529614A true JP2014529614A (ja) 2014-11-13
JP2014529614A5 JP2014529614A5 (enExample) 2015-10-29

Family

ID=46888859

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014527498A Pending JP2014529614A (ja) 2011-08-29 2012-08-29 放射線により誘発されるまたは化学療法により誘発される肺機能不全の治療または予防のための組成物および方法

Country Status (5)

Country Link
US (3) US20140205658A1 (enExample)
EP (1) EP2750696A1 (enExample)
JP (1) JP2014529614A (enExample)
RU (1) RU2014111818A (enExample)
WO (1) WO2013029627A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11033611B2 (en) 2013-11-04 2021-06-15 Board Of Regents, The University Of Texas System Compositions and methods for administration of an enzyme to a subject's airway

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015110536A1 (en) * 2014-01-22 2015-07-30 Reponex Pharmaceuticals Aps Granulocyte-macrophage colony-stimulating factor for the treatment and prevention of severe forms of bronchial asthma

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008109818A1 (en) * 2007-03-07 2008-09-12 Mayo Foundation For Medical Education And Research Treating cancer with granulocyte-macrophage colony stimulating factor
JP2010508365A (ja) * 2006-11-03 2010-03-18 ダラグレキュル・アンパルトセルスカブ 顆粒球マクロファージコロニー刺激因子を投与することによる肺の宿主防御の増強

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5391485A (en) 1985-08-06 1995-02-21 Immunex Corporation DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010508365A (ja) * 2006-11-03 2010-03-18 ダラグレキュル・アンパルトセルスカブ 顆粒球マクロファージコロニー刺激因子を投与することによる肺の宿主防御の増強
WO2008109818A1 (en) * 2007-03-07 2008-09-12 Mayo Foundation For Medical Education And Research Treating cancer with granulocyte-macrophage colony stimulating factor

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ＡＭＥＲＩＣＡＮ ＪＯＵＲＮＡＬ ＯＦ ＣＬＩＮＩＣＡＬ ＯＮＣＯＬＯＧＹ, vol. 26, no. 5, JPN5014010467, 2003, pages 493 - 498, ISSN: 0003358841 *
ＣＬＩＮＩＣＡＬ ＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ, vol. 5, no. 9, JPN6016026847, 1999, pages 2316 - 2323, ISSN: 0003358842 *
ＬＡＮＣＥＴ, vol. 2, no. 8609, JPN6016026856, 1988, pages 471 - 475, ISSN: 0003358846 *
保健物理, vol. 29, no. 3, JPN6016026853, 1994, pages 321 - 326, ISSN: 0003358845 *
肺癌, vol. 24, no. 5, JPN6016026850, 1984, pages 567, ISSN: 0003358844 *
肺癌, vol. 33, no. 2, JPN6016026849, 1993, pages 195 - 205, ISSN: 0003358843 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11033611B2 (en) 2013-11-04 2021-06-15 Board Of Regents, The University Of Texas System Compositions and methods for administration of an enzyme to a subject's airway

Also Published As

Publication number Publication date
EP2750696A1 (en) 2014-07-09
US20160256528A1 (en) 2016-09-08
US20170095534A1 (en) 2017-04-06
RU2014111818A (ru) 2015-10-10
WO2013029627A1 (en) 2013-03-07
US20140205658A1 (en) 2014-07-24

Similar Documents

Publication Publication Date Title
JP6001151B2 (ja) 顆粒球マクロファージコロニー刺激因子を投与することによる肺の宿主防御の増強
US20210121528A1 (en) Compositions for treating lung infections by airway administration
US20080299071A1 (en) Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
US20170095534A1 (en) Compositions and methods for treating or preventing radiation- or chemotherapy-induced pulmonary dysfunction
US20150174204A1 (en) Granulocyte-macrophage colony-stimulating factor for the treatment of bronchial asthma
EP2958582A1 (en) Gm-csf for treatment of chronic oral mucositis
US11426449B2 (en) Methods and compositions for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy
JP7545893B2 (ja) 難治性非結核性マイコバクテリア感染症の治療のためのｇｍ－ｃｓｆ
WO2015110536A1 (en) Granulocyte-macrophage colony-stimulating factor for the treatment and prevention of severe forms of bronchial asthma
WO2014096032A1 (en) Gm-csf for treatment of chronic sinusitis
HK1135911A (en) Enhancing pulmonary host defense via administration of granulocyte-macrophage colony stimulating factor
HK1135911B (en) Enhancing pulmonary host defense via administration of granulocyte-macrophage colony stimulating factor
WO2008116470A1 (en) Enhancing pulmonary host defence via administration of granulocyte- colony stimulating factor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150831

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150831

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160715

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20161014

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20161206

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170313